Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AVBP will decline by -11.32% over the next 2 Weeks and hit $28.14 by Friday, August 7, 2026. In that time frame, AVBP's share price is expected to range between $26.82 and $29.42.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 7, 2026 | 27.26 | 28.63 | 30.03 |
| Aug 6, 2026 | 27.81 | 29.07 | 30.47 |
| Aug 5, 2026 | 27.17 | 28.47 | 29.83 |
| Aug 4, 2026 | 27.34 | 28.57 | 29.85 |
| Aug 3, 2026 | 27.58 | 28.79 | 30.14 |
| Jul 31, 2026 | 28.80 | 30.18 | 31.42 |
| Jul 30, 2026 | 29.31 | 30.62 | 31.91 |
| Jul 29, 2026 | 28.76 | 30.02 | 31.25 |
| Jul 28, 2026 | 28.84 | 30.12 | 31.39 |
| Jul 27, 2026 | 29.03 | 30.34 | 31.66 |
AVBP shares fell -4.95% in Monday, July 27, 2026's trading session, dropping from a previous close of $31.73 to move at $30.16. The stock demonstrated notable intraday movement (see AVBP's key stats for a full breakdown), fluctuating between $30.00 and $32.39, a +7.97% trading range. While recent weeks have seen some volatility, AVBP has managed to secure a -7.31% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 759.26K shares changing hands, 284.3K more than the previous session. This amounted to $22.90M in total market activity.
Will AVBP Continue Its Downward Trend?
According to analyst ratings and projections for AVBP, ArriVent BioPharma, Inc. shares are anticipated to decrease by -0.45%, potentially reaching $30.03 per share by August 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for AVBP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the AVBP stock forecast, now is not the best time to buy AVBP stock because its current trading price is +5.36% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AVBP covering social and institutional perspectives.
AVBP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AVBP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.53% to 45.89%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.31%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.57%, maintains a neutral outlook for the long term. Insights into AVBP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
ArriVent BioPharma Short-Term Forecasts
AVBP Forecast For Next 5 Days
Our algorithm anticipates ArriVent BioPharma (AVBP) stock could hit $33.52 by Aug 03, 2026. This represents a +11.13% rise from today's price, following a +8.90% change over the past five days.
AVBP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for ArriVent BioPharma, Inc. (AVBP) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $32.33, which would mean a +7.19% increase from the current price of $30.16. Projections for this period range from a high of $36.69 to a low of $26.86.
AVBP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for ArriVent BioPharma's price over the next three months point to a rise. AVBP stock is expected to peak at $36.57 on Oct 12, 2026 after potentially dipping to $29.45 on Aug 11, 2026. On average, AVBP is likely to trade around $32.36 in the coming 90 days.
ArriVent BioPharma Stock Forecast 2025
Based on our predictive models, ArriVent BioPharma (AVBP) is expected to trade between $29.45 and $38.50 throughout 2026. This would result in an average price of $32.62, potentially offering investors a +8.16% return from current levels.
ArriVent BioPharma, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, ArriVent BioPharma, Inc. (AVBP) is positioned to show a strong performance in July 2026. The price is predicted to move between $29.67 and $33.33, settling at an average of $31.58. This could translate to a +4.71% gain.
August 2026
Based on current market signals, ArriVent BioPharma, Inc. is projected to trend august 2026. We forecast a trading range from $29.45 to $33.41, with a likely average price of $31.34. Investors could expect a potential return of +3.91%.
September 2026
Our predictive algorithms indicate ArriVent BioPharma, Inc. stock may see a shift in September 2026. The expected range spans $30.07–$35.89, with an average target of $33.22. This represents a positive outlook and a possible gain of +10.15%.
October 2026
Analyzing established trends, ArriVent BioPharma, Inc. looks set to move in October 2026. Projections place the stock between $30.09 and $36.57, averaging around $32.63. This suggests a +8.19% gain from current levels.
November 2026
Market indicators suggest ArriVent BioPharma, Inc. could experience notable changes during November 2026. Prices could fluctuate within $30.67 to $38.50, with a midpoint forecast of $33.37. The stock might deliver a +10.64% gain.
December 2026
Forecasting for December 2026, models estimate that ArriVent BioPharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $30.79 and $35.19, averaging $32.73. This signals a positive trajectory with potential returns around +8.52%.
January 2027
According to our latest forecast models, ArriVent BioPharma, Inc. (AVBP) is positioned to show a strong performance in January 2027. The price is predicted to move between $30.28 and $34.23, settling at an average of $32.26. This could translate to a +6.96% gain.
February 2027
Based on current market signals, ArriVent BioPharma, Inc. is projected to trend february 2027. We forecast a trading range from $31.30 to $37.06, with a likely average price of $34.26. Investors could expect a potential return of +13.59%.
March 2027
Our predictive algorithms indicate ArriVent BioPharma, Inc. stock may see a shift in March 2027. The expected range spans $31.06–$36.22, with an average target of $33.44. This represents a positive outlook and a possible gain of +10.88%.
April 2027
Analyzing established trends, ArriVent BioPharma, Inc. looks set to move in April 2027. Projections place the stock between $31.66 and $36.33, averaging around $34.15. This suggests a +13.23% gain from current levels.
May 2027
Market indicators suggest ArriVent BioPharma, Inc. could experience notable changes during May 2027. Prices could fluctuate within $31.50 to $35.54, with a midpoint forecast of $33.57. The stock might deliver a +11.31% gain.
June 2027
Forecasting for June 2027, models estimate that ArriVent BioPharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $31.03 and $35.29, averaging $33.19. This signals a positive trajectory with potential returns around +10.05%.
July 2027
According to our latest forecast models, ArriVent BioPharma, Inc. (AVBP) is positioned to show a strong performance in July 2027. The price is predicted to move between $32.01 and $37.89, settling at an average of $35.20. This could translate to a +16.71% gain.
AVBP's history of dividends and stock splits also plays a role in long-term investor confidence.

